| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.093 | 0.003 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.085 | 0.003 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.004 |